FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2121618478> ?p ?o ?g. }

• W2121618478 endingPage "35" @default.
• W2121618478 startingPage "2029" @default.
• W2121618478 abstract "Mammalian ribonucleotide reductase is a highly regulated, rate-limiting activity responsible for converting ribonucleoside diphosphates to the deoxyribonucleotide precursors of DNA. The enzyme consists of two nonidentical proteins often called M1 and M2, both of which are required for activity. Hydroxyurea is an antitumor agent which inhibits ribonucleotide reductase by interacting with the M2 component specifically at a unique tyrosyl free radical. To obtain further information about drug resistance mechanisms, we have used M1 and M2 complementary DNAs and monoclonal antibodies to investigate the properties of a series of clonally related drug-resistant mouse cell lines, selected by a step-wise procedure for increasing levels of resistance to the cytotoxic effects of hydroxyurea. Several interesting mechanisms have been identified. Each successive drug selection step leading to the isolation of highly resistant cells was accompanied by stable elevations in cellular resistance and ribonucleotide reductase activities. The changes that occurred at each step involved the M2 component. A very early event, occurring at the first step in the selection process, was the amplification of the M2 gene accompanied by an increase in M2 messenger RNA. Although cellular resistance and M2 protein levels increased significantly during drug selection, only a modest change in M2 gene copy number was observed after the initial selection step. Analysis of wild type, moderately resistant, and highly resistant cells indicated that, in addition to M2 gene amplification, posttranscriptional modification also occurred during drug selection. This second mechanism was not due to alterations in protein M2 half-life, but involved an increase in translational efficiency. By increasing the rate of M2 synthesis, without altering degradation rates, resistant cells were able to accumulate high levels of this key regulatory protein. Cells selected for the ability to proliferate in concentrations of drug as high as 4 mM exhibited changes that involved M2, without detectable changes to M1. These results provide further evidence that M1 and M2 levels are controlled by different mechanisms in mammalian cells. Eventually, however, cells required an elevation in the M1 protein, as well as the M2 protein, to survive in a hydroxyurea concentration of 5 mM. These results illustrate the complexity of the drug-resistant phenotype and provide further information about the molecular processes that lead to the development of cells resistant to low, intermediate, and high concentrations of hydroxyurea." @default.
• W2121618478 created "2016-06-24" @default.
• W2121618478 creator A5016662979 @default.
• W2121618478 creator A5032047953 @default.
• W2121618478 creator A5060124599 @default.
• W2121618478 creator A5067049945 @default.
• W2121618478 creator A5082541160 @default.
• W2121618478 date "1988-04-15" @default.
• W2121618478 modified "2023-09-23" @default.
• W2121618478 title "Molecular mechanisms of drug resistance involving ribonucleotide reductase: hydroxyurea resistance in a series of clonally related mouse cell lines selected in the presence of increasing drug concentrations." @default.
• W2121618478 cites W1505281346 @default.
• W2121618478 cites W1514207813 @default.
• W2121618478 cites W153095713 @default.
• W2121618478 cites W1539690327 @default.
• W2121618478 cites W1544879211 @default.
• W2121618478 cites W1572421367 @default.
• W2121618478 cites W1593424026 @default.
• W2121618478 cites W1934579510 @default.
• W2121618478 cites W1980029052 @default.
• W2121618478 cites W1984367265 @default.
• W2121618478 cites W1986679704 @default.
• W2121618478 cites W1995723741 @default.
• W2121618478 cites W2014669590 @default.
• W2121618478 cites W2035173865 @default.
• W2121618478 cites W2043894159 @default.
• W2121618478 cites W2048956687 @default.
• W2121618478 cites W2060333964 @default.
• W2121618478 cites W2068973845 @default.
• W2121618478 cites W2100837269 @default.
• W2121618478 cites W2178778111 @default.
• W2121618478 cites W284425476 @default.
• W2121618478 cites W2137006890 @default.
• W2121618478 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2832057" @default.
• W2121618478 hasPublicationYear "1988" @default.
• W2121618478 type Work @default.
• W2121618478 sameAs 2121618478 @default.
• W2121618478 citedByCount "19" @default.
• W2121618478 countsByYear W21216184782012 @default.
• W2121618478 countsByYear W21216184782014 @default.
• W2121618478 countsByYear W21216184782016 @default.
• W2121618478 countsByYear W21216184782019 @default.
• W2121618478 countsByYear W21216184782021 @default.
• W2121618478 countsByYear W21216184782022 @default.
• W2121618478 crossrefType "journal-article" @default.
• W2121618478 hasAuthorship W2121618478A5016662979 @default.
• W2121618478 hasAuthorship W2121618478A5032047953 @default.
• W2121618478 hasAuthorship W2121618478A5060124599 @default.
• W2121618478 hasAuthorship W2121618478A5067049945 @default.
• W2121618478 hasAuthorship W2121618478A5082541160 @default.
• W2121618478 hasConcept C104292427 @default.
• W2121618478 hasConcept C104317684 @default.
• W2121618478 hasConcept C114851261 @default.
• W2121618478 hasConcept C134651460 @default.
• W2121618478 hasConcept C153911025 @default.
• W2121618478 hasConcept C181199279 @default.
• W2121618478 hasConcept C4710235 @default.
• W2121618478 hasConcept C512185932 @default.
• W2121618478 hasConcept C54355233 @default.
• W2121618478 hasConcept C552990157 @default.
• W2121618478 hasConcept C55493867 @default.
• W2121618478 hasConcept C81885089 @default.
• W2121618478 hasConcept C86803240 @default.
• W2121618478 hasConcept C98892162 @default.
• W2121618478 hasConceptScore W2121618478C104292427 @default.
• W2121618478 hasConceptScore W2121618478C104317684 @default.
• W2121618478 hasConceptScore W2121618478C114851261 @default.
• W2121618478 hasConceptScore W2121618478C134651460 @default.
• W2121618478 hasConceptScore W2121618478C153911025 @default.
• W2121618478 hasConceptScore W2121618478C181199279 @default.
• W2121618478 hasConceptScore W2121618478C4710235 @default.
• W2121618478 hasConceptScore W2121618478C512185932 @default.
• W2121618478 hasConceptScore W2121618478C54355233 @default.
• W2121618478 hasConceptScore W2121618478C552990157 @default.
• W2121618478 hasConceptScore W2121618478C55493867 @default.
• W2121618478 hasConceptScore W2121618478C81885089 @default.
• W2121618478 hasConceptScore W2121618478C86803240 @default.
• W2121618478 hasConceptScore W2121618478C98892162 @default.
• W2121618478 hasIssue "8" @default.
• W2121618478 hasLocation W21216184781 @default.
• W2121618478 hasOpenAccess W2121618478 @default.
• W2121618478 hasPrimaryLocation W21216184781 @default.
• W2121618478 hasRelatedWork W1572240235 @default.
• W2121618478 hasRelatedWork W1584870064 @default.
• W2121618478 hasRelatedWork W1800473089 @default.
• W2121618478 hasRelatedWork W1979362723 @default.
• W2121618478 hasRelatedWork W1986778880 @default.
• W2121618478 hasRelatedWork W1991737003 @default.
• W2121618478 hasRelatedWork W2002733095 @default.
• W2121618478 hasRelatedWork W2016936486 @default.
• W2121618478 hasRelatedWork W2058704920 @default.
• W2121618478 hasRelatedWork W2083419573 @default.
• W2121618478 hasVolume "48" @default.
• W2121618478 isParatext "false" @default.
• W2121618478 isRetracted "false" @default.
• W2121618478 magId "2121618478" @default.
• W2121618478 workType "article" @default.